Research & Development
Lucence promotes study of LiquidHallmark biopsy assay
LiquidHallmark is an amplicon-based next-generation sequencing assay developed for the genomic profiling of plasma-derived cell-free DNA (cfDNA). The 80-gene panel profiles point mutations, insertions/deletions, copy number alterations, and gene fusions, and further detects oncogenic viruses (Epstein-Barr virus [EBV] and hepatitis B virus [HBV]) and microsatellite instability (MSI), according to the company.
May 18, 2022
USPSTF renews support for routine hepatitis B screening
The statement on hepatitis B gives a grade A recommendation -- meaning the task force has high confidence in the evidence -- for routine screening with the hepatitis B surface antigen (HBsAg) test for all pregnant women. Ideally, testing should be performed in the first trimester, but it should at least be done in an early prenatal visit, according to Stanford University health policy expert Dr. Douglas Owens and colleagues on the task force (JAMA, July 23/30, 2019, Vol. 322:4, pp. 349-354).
July 22, 2019
Page 1 of 1